Aster Capital Management
ANIP icon

Aster Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Aster Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.77K Buy
+107
New +$8.24K ﹤0.01% 802
2026
Q2 		– Sell
-54
Closed -$3.62K – 836
2026
Q1 		$3.62K Buy
+54
New +$4.22K ﹤0.01% 709
2025
Q2 		– Sell
-2,193
Closed -$136K – 1018
2025
Q1 		$136K Buy
+2,193
New +$131K 0.03% 579

Other funds holding ANIP

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Ranger Investment Management
Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Aster Capital Management's ANIP Position: Q3 2026 in Review

Aster Capital Management opened a new position in ANI Pharmaceuticals (ANIP) in Q3 2026: 107 shares worth $7.77K. The stake represents ﹤0.01% of the portfolio and ranks #802 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in ANIP as recently as Q1 2026.

Aster Capital Management first reported a position in ANIP in Q1 2025 and has held it in 3 quarters since. The position peaked at $136K in Q1 2025. 154 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Aster Capital Management held 107 shares of ANI Pharmaceuticals worth $7.77K as of Q3 2026.
  • ANI Pharmaceuticals was a new Aster Capital Management position in Q3 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #802 holding.
  • Aster Capital Management first reported a position in ANI Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • Aster Capital Management's ANI Pharmaceuticals position peaked at $136K in Q1 2025.
  • 154 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.